Refresh
X
Gainers
Losers
Sectors
Indices
Forex
Mutual Funds
Home
Indices
Sectors
Mutual Funds
Gainers
Losers
Forex
Investment Tool
All Pages
Lyons Corporate Market Ltd.
BSE
Price on BSE
27 Sep,09:48 LIVE
6.43
+1.07
(+19.96%)
© 2024 Rediff.com
Volume :
300.00
Prev Close :
5.36
Day's H/L (Rs.) :
6.43 - 6.43
52wk H/L (Rs.) :
5.36 - 4.87
Mkt Cap (Rs. Cr) :
3.03
NSE
Lyons Corporate Market Ltd. is not listed on NSE
© 2024 Rediff.com
Report Card - Lyons Corporate Market Ltd.
PE Ratios
-138.62
EPS (Rs.)
-0.05
Sales (Rs. Cr)
0.22
Face Value (Rs.)
10
Net Profit Margin(%)
11.00
Last Bonus
-
Last Dividend(%)
-
Return on Average Equity
0.75
News for Finance
Dr Reddy's Licenses Gilead's HIV Drug Lenacapavir
Dr Reddy's Laboratories has partnered with Gilead Sciences to manufacture and commercialize the HIV drug Lenacapavir in India and 120 other countries. The drug is indicated for treatment of...
Oct 02, 2024 19:52
Indian Businesses Eye UK Expansion: Report
A new report reveals the UK is a top choice for Indian businesses looking to expand internationally. An India-UK free trade agreement is expected to further boost this trend.
Oct 02, 2024 19:50
Lava Agni 3: Smartphone with Rear Display Launching Oct 4
Lava to launch Agni 3 smartphone series with a rear display on October 4. This innovative phone features a rear display for calls, messages, and selfies using the main camera.
Oct 02, 2024 19:40
Hetero & Gilead Partner for HIV Drug Lenacapavir Access
Hetero and Gilead have partnered to expand access to lenacapavir, a groundbreaking HIV treatment, in 120 low- and middle-income countries. This partnership aims to improve treatment options and...
Oct 02, 2024 19:23
Tesla Q3 Deliveries Rise: Price Cuts, Financing Boost Sales
Tesla's global deliveries increased in Q3, driven by price cuts, financing deals, and free charging. The company delivered 462,890 vehicles, exceeding analyst estimates.
Oct 02, 2024 19:22
More News »
Top News
Dr Reddy's Licenses Gilead's HIV Drug Lenacapavir
Dr Reddy's Laboratories has partnered with Gilead Sciences to manufacture and commercialize the HIV drug Lenacapavir in India and 120 other countries. The drug is indicated for treatment of...
Oct 02, 2024 19:52
Indian Businesses Eye UK Expansion: Report
A new report reveals the UK is a top choice for Indian businesses looking to expand internationally. An India-UK free trade agreement is expected to further boost this trend.
Oct 02, 2024 19:50
Lava Agni 3: Smartphone with Rear Display Launching Oct 4
Lava to launch Agni 3 smartphone series with a rear display on October 4. This innovative phone features a rear display for calls, messages, and selfies using the main camera.
Oct 02, 2024 19:40
Hetero & Gilead Partner for HIV Drug Lenacapavir Access
Hetero and Gilead have partnered to expand access to lenacapavir, a groundbreaking HIV treatment, in 120 low- and middle-income countries. This partnership aims to improve treatment options and...
Oct 02, 2024 19:23
Tesla Q3 Deliveries Rise: Price Cuts, Financing Boost Sales
Tesla's global deliveries increased in Q3, driven by price cuts, financing deals, and free charging. The company delivered 462,890 vehicles, exceeding analyst estimates.
Oct 02, 2024 19:22
More Top News »
Sectoral Indices
Market Indicators
Listed Companies
Gainers
Losers
Mutual Funds
Portfolio
Watchlist